Workflow
United Winners Laser(688518)
icon
Search documents
联赢激光:固态电池设备获突破 全年45亿元目标有望达成
南方财经11月4日电,联赢激光(688518.SH)在2025年10月30日的调研中表示,公司在半固态电池设备 领域已积累多个亿订单,全固态电池设备方面已为两家行业头部客户提供中试线设备并进入试产阶段, 另有其他电池厂正在进行技术对接,预计2026年将有更多客户与产品落地。公司回应,相关设备覆盖激 光焊接、激光清洗(刻痕)及涂胶设备,当前全固态电池仍处研发阶段,以小试线和中试线为主,尚未 进入大规模量产。公司表示,今年新签订单同比大幅增长,截至当前已超去年全年水平,全年目标45亿 元(含税)有望达成,其中锂电领域占比约七成,主要来自头部客户。 ...
联赢激光(688518):Q3营收及利润增长稳健,看好3C业务带来盈利弹性释放
上 市 公 司 机械设备 2025 年 11 月 03 日 联赢激光 (688518) ——Q3 营收及利润增长稳健,看好 3C 业务带来盈利弹 性释放 报告原因:有业绩公布需要点评 买入(维持) | 市场数据: | 2025 年 10 月 31 日 | | --- | --- | | 收盘价(元) | 26.07 | | 一年内最高/最低(元) | 28.55/13.28 | | 市净率 | 2.8 | | 股息率%(分红/股价) | 0.58 | | 流通 A 股市值(百万元) | 8,898 | | 上证指数/深证成指 | 3,954.79/13,378.21 | | 注:"股息率"以最近一年已公布分红计算 | | | 基础数据: | 2025 年 09 月 30 日 | | --- | --- | | 每股净资产(元) | 9.38 | | 资产负债率% | 59.06 | | 总股本/流通 A 股(百万) | 341/341 | | 流通 B 股/H 股(百万) | -/- | 一年内股价与大盘对比走势: 10-31 11-30 12-31 01-31 02-28 03-31 04-30 05-31 ...
联赢激光(688518) - 深圳市联赢激光股份有限公司2025年第一次临时股东大会会议资料
2025-11-03 09:30
深圳市联赢激光股份有限公司 2025 年第一次临时股东大会会议资料 证券代码:688518 证券简称:联赢激光 深圳市联赢激光股份有限公司 2025 年第一次临时股东大会会议资料 二零二五年十一月 1 | | | 深圳市联赢激光股份有限公司 2025 年第一次临时股东大会会议资料 深圳市联赢激光股份有限公司 2025年第一次临时股东大会会议须知 为了维护全体股东的合法权益,确保股东大会的正常秩序及议事效率,保证 大会的顺利进行,根据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司股东大会规则》以及《深圳市联赢激光股份有限公司章程》《深圳市联赢 激光股份有限公司股东大会议事规则》等相关规定,深圳市联赢激光股份有限公 司(以下简称"公司")特制定2025年第一次临时股东大会会议须知: 一、为确认出席大会的股东或其代理人或其他出席者的出席资格,会议工作 人员将对出席会议者的身份进行必要的核对工作,请被核对者给予配合。出席会 议的股东及股东代理人须在会议召开前30分钟到会议现场办理签到手续,并请按 规定出示证券账户卡、身份证明文件或法人单位证明、授权委托书等,经验证后 方可出席会议。 二、为保证本次大会的 ...
联赢激光股价跌5.02%,华安基金旗下1只基金位居十大流通股东,持有474.33万股浮亏损失621.37万元
Xin Lang Cai Jing· 2025-11-03 03:11
截至发稿,饶晓鹏累计任职时间11年311天,现任基金资产总规模62.39亿元,任职期间最佳基金回报 194.11%, 任职期间最差基金回报-28.57%。 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 责任编辑:小浪快报 数据显示,华安基金旗下1只基金位居联赢激光十大流通股东。华安聚优精选混合(009714)三季度新 进十大流通股东,持有股数474.33万股,占流通股的比例为1.39%。根据测算,今日浮亏损失约621.37 万元。 华安聚优精选混合(009714)成立日期2020年7月16日,最新规模41.47亿。今年以来收益18.59%,同类 排名4679/8223;近一年收益13.54%,同类排名5258/8115;成立以来亏损27.98%。 华安聚优精选混合(009714)基金经理为饶晓鹏。 11月3日,联赢激光跌5.02%,截至发稿,报24.76元/股,成交2.05亿元,换手率2.36%,总市值84.51亿 元。 资料显示,深圳市联赢激光股份有限公司位于广东省深 ...
联赢激光20251030
2025-10-30 15:21
Summary of the Conference Call for Lianwin Laser Company Overview - **Company**: Lianwin Laser - **Industry**: Laser equipment manufacturing, focusing on lithium battery and consumer electronics sectors Key Financial Metrics - **Q3 2025 Revenue**: 714 million CNY, a decrease of 3.97% year-on-year [2][3] - **Net Profit**: 50.18 million CNY, an increase of 15.17% year-on-year [2][3] - **Total Revenue for First Three Quarters**: 2.248 billion CNY, a growth of 2.16% year-on-year [3] - **Gross Margin**: 29.42% for the first three quarters, a decrease of 0.3 percentage points [3] - **Q3 Gross Margin**: 33.93%, an increase of 2.09 percentage points year-on-year [3] Revenue Composition - **Revenue Breakdown**: - Complete equipment: 58.44% - Workbenches: 20% - Main units (lasers): 8% - Other services: 10% [2][6] - **Industry Contribution**: - Lithium battery sector: 67% - Non-lithium battery sector: 31% - Consumer electronics contributed over 400 million CNY, primarily from small steel shell orders [2][6][9] Asset and Cash Flow Situation - **Total Assets**: 7.829 billion CNY, an increase of 11.13% from the previous year [7] - **Net Assets**: 3.2 billion CNY, an increase of 1.76% [7] - **Accounts Receivable**: Over 1.6 billion CNY, an increase of 2.7% [7] - **Inventory**: Over 2.4 billion CNY, an increase of 17% [7] - **Contract Liabilities**: Over 1.5 billion CNY, an increase of 20% [7] - **Operating Cash Flow**: Over 100 million CNY, showing significant year-on-year growth [7] Expense Management - **Expense Ratio**: 26% for the first three quarters, stable year-on-year; however, Q3 saw an increase to 30%, up 3 percentage points [8] - **Management Expenses**: Increased significantly due to hiring, reaching 20% in Q3 [8][20] Market Dynamics and Future Outlook - **Consumer Electronics**: Expected to maintain growth, with significant contributions from small steel shell projects [4][21] - **New Orders**: Significant growth in new orders, with total orders expected to reach around 4 billion CNY [11] - **Solid-State Battery Equipment**: Initial deliveries made, but most clients are still in R&D stages [15][19] - **2026 Outlook**: Demand in both lithium and non-lithium sectors expected to remain stable or grow [18] Strategic Initiatives - **Expansion into New Markets**: Actively exploring general automation fields, including hydrogen fuel and medical devices [4][25] - **Collaboration with Key Clients**: Engaging with major clients like CATL for future expansions [14] - **International Business**: Limited direct overseas clients, but following domestic leaders in international projects [22] Emerging Technologies - **New Product Development**: Focus on solid-state technology and new laser applications [16][25] - **Efficiency in Production**: Current production efficiency is low, with improvements expected as products move to mass production [17] Conclusion Lianwin Laser is navigating a challenging market environment with a focus on expanding its product offerings and maintaining strong relationships with key clients. The company is poised for potential growth in 2026, driven by new orders and strategic initiatives in emerging technologies.
联赢激光:2025年前三季度净利润约1.08亿元
Mei Ri Jing Ji Xin Wen· 2025-10-29 14:08
Group 1 - The core viewpoint of the article highlights the financial performance of Lianying Laser in Q3 2025, showing a revenue increase and profit growth compared to the previous year [1] - The company's revenue for the first three quarters of 2025 is approximately 2.248 billion yuan, representing a year-on-year increase of 2.16% [1] - The net profit attributable to shareholders is around 108 million yuan, reflecting a year-on-year increase of 14.08% [1] - Basic earnings per share stand at 0.32 yuan, which is a 14.29% increase year-on-year [1] Group 2 - As of the report, Lianying Laser has a market capitalization of 8.8 billion yuan [2] - The A-share market has surpassed 4000 points, indicating a significant market resurgence and a new "slow bull" pattern driven by technology [2]
联赢激光(688518) - 2025 Q3 - 季度财报
2025-10-29 10:05
Financial Performance - The company's operating revenue for Q3 2025 was ¥714,234,532.02, a decrease of 3.97% compared to the same period last year[3]. - The total profit for the period was ¥47,397,433.65, reflecting an increase of 3.85% year-on-year[3]. - The net profit attributable to shareholders was ¥50,178,950.53, up 15.17% from the previous year[3]. - The net profit after deducting non-recurring gains and losses was ¥46,086,418.55, representing a 23.19% increase year-on-year[3]. - The basic earnings per share for the period was ¥0.15, an increase of 15.38% compared to the same period last year[4]. - Total operating revenue for the first three quarters of 2025 reached ¥2,247,585,271.74, a slight increase of 2.5% compared to ¥2,199,975,605.81 in the same period of 2024[18]. - Net profit for the first three quarters of 2025 was ¥102,775,072.71, representing a significant increase of 13.2% from ¥90,757,455.62 in the previous year[20]. - The profit attributable to shareholders of the parent company was ¥108,097,584.54, compared to ¥94,754,005.36 in the same period last year, marking a growth of 14.0%[20]. - Basic and diluted earnings per share for the period were both ¥0.32, up from ¥0.28 in the previous year[20]. Assets and Liabilities - The total assets at the end of the reporting period reached ¥7,829,329,980.37, an increase of 11.13% from the end of the previous year[4]. - Total current assets as of September 30, 2025, amount to ¥6,222,360,342.81, an increase from ¥5,631,443,870.00 at the end of 2024[13]. - Total assets increased to ¥7,829,329,980.37 from ¥7,045,471,402.41 year-over-year[14]. - Total liabilities increased to ¥4,494,058,644.88 from ¥3,840,888,804.35 year-over-year[14]. - Total liabilities increased to ¥4,624,062,103.43 from ¥3,895,607,556.81, indicating a rise of 18.7%[19]. - Total equity attributable to shareholders of the parent company reached ¥3,202,292,507.17, compared to ¥3,146,815,238.21, reflecting an increase of 1.8%[19]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥145,287,369.06, a significant improvement from a negative cash flow in the same period last year[8]. - The net cash flow from operating activities for the first three quarters of 2025 was ¥145,287,369.06, a significant improvement compared to a net outflow of ¥331,791,868.44 in the same period of 2024[23]. - Total cash inflow from operating activities increased to ¥2,285,014,630.49 in 2025, up from ¥1,784,858,963.56 in 2024, representing a growth of approximately 28.0%[23]. - Cash outflow from investing activities decreased to ¥1,085,305,589.45 in 2025 from ¥1,813,501,405.38 in 2024, indicating a reduction of about 40.2%[24]. - The net cash flow from investing activities improved slightly to -¥406,055,768.07 in 2025, compared to -¥433,899,019.72 in 2024[24]. - Cash inflow from financing activities was ¥612,213,574.66 in 2025, slightly down from ¥615,111,744.52 in 2024[24]. - The net cash flow from financing activities decreased to ¥119,125,029.02 in 2025, down from ¥432,618,354.92 in 2024[24]. - The ending cash and cash equivalents balance increased to ¥635,463,991.65 in 2025, compared to ¥528,838,066.72 in 2024, reflecting a growth of approximately 20.2%[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,130[10]. - The largest shareholder, Han Jinlong, holds 28,724,356 shares, representing 8.42% of total shares[11]. - The company has no significant changes in the top 10 shareholders or their participation in margin trading[12]. - The company reported no significant related party transactions among major shareholders[12]. Expenses and Income - Research and development expenses amounted to ¥53,276,288.94, accounting for 7.46% of operating revenue, which is an increase of 0.05 percentage points[4]. - The company reported a decrease in financial expenses from ¥4,152,225.05 to ¥1,108,629.07, a reduction of approximately 73.3%[19]. - Other income decreased to ¥72,627,113.38 from ¥88,958,955.36, a decline of 18.3%[19]. - The company’s deferred income increased to ¥26,824,555.63 from ¥8,536,620.88, showing a substantial rise of 213.5%[19].
联赢激光(688518) - 深圳市联赢激光股份有限公司关于召开2025年第一次临时股东大会的通知
2025-10-24 10:45
证券代码:688518 证券简称:联赢激光 公告编号:2025-029 深圳市联赢激光股份有限公司 关于召开2025年第一次临时股东大会的通知 (四) 现场会议召开的日期、时间和地点 召开日期时间:2025 年 11 月 10 日 14 点 30 分 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一) 股东大会类型和届次 2025年第一次临时股东大会 (二) 股东大会召集人:董事会 (三) 投票方式:本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 召开地点:深圳市坪山区坑梓街道沙田社区荣沙路 18 号 A 栋联赢大厦二楼 会议室 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东大会网络投票系统 网络投票起止时间:自2025 年 11 月 10 日 至2025 年 11 月 10 日 股东大会召开日期:2025年11月10日 本次股东大会采用的网络投票系统:上海证券交易所股东大会网络投票 系统 采用上海证券交易所网络投票系统,通过交易系 ...
联赢激光(688518) - 深圳市联赢激光股份有限公司第五届监事会第九次会议决议公告
2025-10-24 10:45
深圳市联赢激光股份有限公司 第五届监事会第九次会议决议公告 公司监事会及全体监事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码:688518 证券简称:联赢激光 公告编号:2025-026 一、监事会会议召开情况 深圳市联赢激光股份有限公司(以下简称"公司")第五届监事会第九次会 议于2025年10月24日上午以现场与通讯表决结合的方式召开,应到监事3人,实 到监事3人。会议的召集召开符合法律法规和公司章程规定。经与会监事审议, 一致同意通过如下决议: 二、监事会会议审议情况 表决结果:同意3票,反对0票,弃权0票。 (二)审议通过《关于使用暂时闲置募集资金进行现金管理的议案》。 表决结果:同意3票,反对0票,弃权0票。 特此公告。 深圳市联赢激光股份有限公司监事会 2025年10月25日 经与会监事讨论,审议通过了如下议案: (一)审议通过《关于取消监事会、变更经营范围、修订<公司章程>并办 理工商变更登记的议案》。 ...
联赢激光:10月24日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-10-24 10:41
Group 1 - The core point of the article is that Lianying Laser (SH 688518) held its 10th meeting of the 5th board of directors on October 24, 2025, to discuss the proposal for the 2025 first extraordinary general meeting of shareholders [1] - For the year 2024, Lianying Laser's revenue composition is as follows: 71.53% from power batteries, 17.5% from consumer electronics, 6.17% from automotive and hardware, 2.42% from other businesses, and 2.22% from other industries [1] - As of the report date, Lianying Laser has a market capitalization of 8.8 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year, highlighting the booming secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]